Preparation of cefpodoxime proxetil fine particles using supercritical fluids

International Journal of Pharmaceutics

Volumn 369, Issue 1-2, 2009, Pages 85-91

  Chu, Junho ^a   Li, Guanghua ^b   Row, Kyung Ho ^b   Kim, Hwayong ^a   Lee, Youn Woo ^a  

^a Seoul National University   (South Korea)

^b Inha University   (South Korea)

Author keywords

Aerosol Solvent Extraction System; Cefpodoxime proxetil; Particle formation; Supercritical carbon dioxide

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; CARBON DIOXIDE; CEFPODOXIME PROXETIL; SOLVENT;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG SYNTHESIS; MEMBRANE FILTER; PARTICLE SIZE; PRIORITY JOURNAL;

ACETATES; ACETONE; AEROSOLS; ANTI-BACTERIAL AGENTS; CARBON DIOXIDE; CEFTIZOXIME; CHEMISTRY, PHARMACEUTICAL; MEMBRANES, ARTIFICIAL; PARTICLE SIZE; POWDERS; SOLUBILITY; SOLVENTS;

EID: 60849105061     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.10.029     Document Type: Article

References (16)

1. 2 in green chemical synthesis and processing. J. Supercrit. Fluids 28 (2004) 121-191
2. Borin T. A review of the pharmacokinetics of Cefpodoxime proxetil. Drugs 42 (1991) 13-21
3. Choi S., Lee K., Kwon S., and Kim H. Preparation of fine particles of poly(N-vinyl-2-pyrrolidone-co-2-methylene-1,3-dioxepane) using supercritical antisolvent. J. Supercrit. Fluids 37 (2006) 287-291
4. Crauste-Manciet S., Huneau J.F., Decroix M.O., Tome D., and Chaumeil J.C. Cefpodoxime proxetil esterase activity in rabbit small intestine: role in the partial Cefpodoxime absorption. Int. J. Pharm. 149 (1997) 241-249
5. Date A.A., and Nagarsenker M.S. Design and evaluation of self-nanoemulsifying drug delivery system (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 329 (2007) 166-172
6. Jung J., and Perrut M. Particle design using supercritical fluids: literature and patent survey. J. Supercrit. Fluids 20 (2001) 179-219
7. Kakumanu V.K., Arora V., and Bansal A.K. Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil. Int. J. Pharm. 317 (2006) 155-160
8. Kim J.-S., Kim M.-S., Park H.J., Jin S.-J., Lee S., and Hwang S.-J. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. Int. J. Pharm. 359 (2008) 211-219
9. Kim M.-S., Jin S.-J., Kim J.-S., Park H.J., Song H.-S., Neubert R.H.H., and Hwang S.-J. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur. J. Pharm. Biopharm. 69 (2008) 454-465
10. Kumar, Y., Arora, R.K., Singh, K., 2003. Amorphous form of cefpodoxime proxetil. US Patent 6,602,000B1.
11. Kumar, Y., Singh, K., Arora, R.K., 2006. Cefpodoxime proxetil. US Patent 7,045,618B2.
12. Li G., Chu J., Row K.H., Lee K.-H., and Lee Y.-W. Crystallization of acetaminophen micro-particle using supercritical carbon dioxide. Korean J. Chem. Eng. 23 (2006) 482-487
13. Nicolaos G., Crauste-Manciet S., Farinotti R., and Brossard D. Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion. Int. J. Pharm. 263 (2003) 165-171
14. Reverchon E. Supercritical antisolvent precipitation of micro-and nano-particles. J. Supercrit. Fluids 15 (1999) 1-21
15. Thiering R., Dehghani F., and Foster N.R. Current issues relating to anti-solvent micronisation techniques and their extension to industrial scales. J. Supercrit. Fluids 21 (2001) 159-177
16. Yeo S.-D., and Kiran E. Formation of polymer particles with supercritical fluids: a review. J. Supercrit. Fluids 34 (2005) 287-308